| Having trouble viewing this email? View it as a Web page. | |
| |  HHS Continues Community Based Testing Sites for COVID-19 Today, the Department of Health and Human Services (HHS) announced the extension of the Community Based Testing Site program for COVID-19 testing, through partnership with national pharmacy and retail chains CVS, Rite-Aid, Walgreens, Quest (through services at Walmart) and service provider eTrueNorth (through services at Health Mart and Topco locations). The partnership has resulted in establishing more than 3,300 COVID-19 testing locations in all 50 states, the District of Columbia, and Puerto Rico. To date, more than 5.6 million tests have been conducted as a result of this partnership. The Community Based Testing Site program began in the spring of 2020 and includes a large percentage - over 70% - of testing sites located in communities with moderate-to-high social vulnerability, as evidenced by their racial and ethnic composition, their household composition, their socioeconomic status, and similar considerations. | HHS Releases National Strategic Plan to Address Viral Hepatitis The U.S. Department of Health and Human Services (HHS) released a national plan to address the serious, preventable public health threat caused by viral hepatitis in the United States. The Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021–2025 sets national goals, objectives, and strategies to respond to viral hepatitis epidemics. Building on three prior National Viral Hepatitis Action Plans over the last 10 years, the Viral Hepatitis National Strategic Plan is the first to aim for elimination of viral hepatitis as a public health threat in the United States by 2030. This plan serves as a roadmap for stakeholders at all levels and across many sectors, both public and private, to guide development of policies, initiatives, and actions for viral hepatitis prevention, screening, care, treatment, and cure. | | | |
No comments:
Post a Comment